Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib in Stage III BRAF-Mutated Melanoma"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Axel Hauschild
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Axel Hauschild
527 views
June 11, 2024
Comments 0
Login to view comments.
Click here to Login